Pharma BD Deal Intelligence

Shire plc / Baxalta Inc.

2016 · Acquisition/Merger · $32.0B · Complete

Announcement Sentiment

36

Skeptical

Outcome Score

77

Worked — the deal delivered on its rationale.

Shire acquired Baxalta for $32B for rare disease and hematology.

Key facts

Announced Jan 22, 2016
Closed Jun 03, 2016
Deal value $32.0B
Deal type Acquisition/Merger
Therapeutic area Hematology

See the full interactive analysis, sources & comparables →

← Browse all deals · How we score deals